FHFang Huang

Fang Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fang Huang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Donglei Liu

    Beijing Center for Disease Control and Prevention, 16 Hepingli Middle Road, Dongcheng District, Beijing 100013, China

    1 shared publication
  • Guo-Hong Huang

    WHO WPRO Regional Polio Reference Laboratory, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd, Changping District, Beijing, 102206, PR China.

    1 shared publication
  • Jiang Wu

    Institute of Immunization and Prevention of Beijing Center for Disease Prevention and Control, 16, Hepingli Middle Avenue, Dongcheng District, Beijing 100013, China

    1 shared publication
  • Meng Chen

    Beijing Centers for Disease Control and Prevention, No. 16, Hepingli Middle Street, Dongcheng district, Beijing, 100013, People’s Republic of China

    1 shared publication
  • Meng Chen

    Beijing Center for Disease Prevention and Control, Beijing 100013, China

    1 shared publication
  • Naiying Mao

    WHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, 102206, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Whole genomic analysis of two potential recombinant strains within Human mastadenovirus species C previously found in Beijing, China

    by Naiying Mao, Zhen Zhu, Pierre Rivailler, Meng Chen, Qin Fan, Fang Huang, Wenbo Xu

    Human mastadenovirus species C (HAdV-C) are the most common etiologic agents of respiratory disease in young children and are frequently detected worldwide including China. Two recombinant HAdV-C strains (BJ04 and BJ09) were isolated from infants with acute respiratory infection (ARI) in Beijing in 2012–2013. The whole genome sequences (WGS) of BJ04 and BJ09 were generated and compared to other 35 HAdV-C WGSs publicly available. Phylogenetic analyses showed that the BJ04 strain might be the result of three homologous recombination events involving the parental strains JX173086 (HAdV-1), NC_001405 (HAdV-2) and LC068718 (HAdV-6), whereas BJ09 viral genome might be made of genetic elements from JX173083 (HAdV-1), KF268199 (HAdV-5), and KR699642 (strain CBJ113). Despite intratypic recombination, amino acid analysis showed that the gene repertoire of BJ04 and BJ09 were similar to type 2 viruses. Finally, this analysis revealed that at least three lineages of HAdV-C have been identified in China, represented by BJ04 related to NC_001405, BJ09 related to CBJ113, and KF951595 (strain DD28) related to virus isolated in Japan. This study showed that the frequent recombination played an important driving force for complexity of the HAdV-C epidemic in Beijing, thereby demonstrating the necessity for epidemiological and virological surveillance for HAdV-C in China.


  • Open Access

    Rubella epidemic caused by genotype 1E rubella viruses in Beijing, China, in 2007–2011

    by Meng Chen, Zhen Zhu, Donglei Liu, Guohong Huang, Fang Huang, Jiang Wu, Tiegang Zhang, Wenbo Xu, Xinghuo Pang

    Background: A series of different rubella vaccination strategies were implemented to control rubella and prevent congenital rubella virus infection in Beijing, China. The rubella vaccine was available in 1995 in Beijing, and was introduced into the Beijing immunization program (vaccine recipients at their own expense vaccination) in 2000, and was introduced into the National Expanded Program on Immunization (vaccine recipients free vaccination) in 2006. Rubella virological surveillance started in Beijing in 2007. Results: The reported rubella incidence rate has decreased dramatically due to the introduction of the vaccine in Beijing since 1995. However, rubella epidemics occurred regardless in 2001 and 2007. The incidence rate among the floating population has gradually increased since 2002, reaching 2 or more times that in the permanent resident population. The peak age of rubella cases gradually changed from <15 years of age to adults after 2005. Phylogenetic analysis was performed and a phylogenetic tree was constructed based on the World Health Organization standard sequence window for rubella virus isolates. All Beijing rubella virus isolates belong to genotype 1E/cluster1 and were clustered interspersed with viruses from other provinces in China. The effective number of infections indicated by a Bayesian skyline plot remained constant from 2007 to 2011. Conclusions: The proportion of rubella cases among the floating population has increased significantly in Beijing since 2002, and the disease burden gradually shifted to the older age group (15- to 39-year olds), which has become a major group with rubella infection since 2006. Genotype 1E rubella virus continuously caused a rubella epidemic in Beijing in 2007–2011 and was the predominant virus, and all Beijing genotype 1E viruses belong to cluster 1, which is also widely circulated throughout the country.